An investigation for investors in NASDAQ:CBYL shares over potential securities laws violations by Carbylan Therapeutics was announced and NASDAQ:CBYL stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 04/13/2016 -- An investigation for shareholders of Carbylan Therapeutics Inc (NASDAQ:CBYL) was announced over potential securities laws violations by Carbylan Therapeutics in connection certain financial statements.
Investors who purchased shares of Carbylan Therapeutics Inc (NASDAQ:CBYL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Carbylan Therapeutics Inc (NASDAQ:CBYL) concerning whether a series of statements by Carbylan Therapeutics regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Carbylan Therapeutics Inc went public in early April 2015 and sold in its initial public stock offering 13 million shares of stock, raising $65.0 million in new capital. Shares of Carbylan Therapeutics Inc (NASDAQ:CBYL) reached on June 8, 2015 as high as $9.22 per share. However, since then, Carbylan Therapeutics' stock declined to as low as $0.55 per share on March 24, 2016.
Those who purchased shares of Carbylan Therapeutics Inc (NASDAQ:CBYL) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com